Arnaud Pierre Daniel Legland

CE No. BLH839 Active

This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Arnaud Pierre Daniel Legland, a licensed Representative with CE reference BLH839. Currently licensed at 1 firm(s): Gavekal Capital Limited. Active regulated activities: Type 9 - Asset management. This person has 8.7 years of SFC licence history. Total licence records on file: 1.

Information

LinkedIn:
Email:

Licence history

FirmRoleRegulated activityFromTo
Gavekal Capital Limited Rep Type 9 - Asset management 2017-11-17 present

Worked alongside

The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Arnaud Pierre Daniel Legland during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.

NameShared firmOverlap
Louis Vincent Gave Gavekal Capital Limited 2017–present
Alfred Kai Shing Ho Gavekal Capital Limited 2017–present
Christine Wai Kan Cheung Gavekal Capital Limited 2017–present
Tsz Wai Luk Gavekal Capital Limited 2017–present
Meng Ji Zhao Gavekal Capital Limited 2017–present
Dick Lam Poon Gavekal Capital Limited 2017–2026
Sebastien Alfonsi Gavekal Capital Limited 2017–2024
Yu Hei Ng Gavekal Capital Limited 2020–present
Michael Charles Georges Jacques Marie de Mollerat Du Jeu Gavekal Capital Limited 2017–2023
Jacques Didier Darcet Gavekal Capital Limited 2017–2023
Charles Jean Hubert Gave Gavekal Capital Limited 2017–2023
Ngai Kwong Chan Gavekal Capital Limited 2021–present
Jonathan Jiancong Kok Gavekal Capital Limited 2017–2022
Marco Sai Chung Lai Gavekal Capital Limited 2017–2022
Eric Chi Ho Wong Gavekal Capital Limited 2017–2021
Chung Hui Lor Gavekal Capital Limited 2021–2024
Chun Wai Heung Gavekal Capital Limited 2021–2023
Owen Ngo Wang Mok Gavekal Capital Limited 2022–2024
Gavin See-Yin Ma Gavekal Capital Limited 2017–2019
Leonid Mironov Gavekal Capital Limited 2025–present
Explore the interactive colleague network →

Related